Delivery Order SPE2DB20D1100-SPE2DB25FC3G1

Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,419.31, is for the delivery of the prescription medication Biktarvy, a treatment for HIV. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,481.60 delivery order contract is for the drug Biktarvy, which is used to treat HIV, and has a completion date of December 3, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV. The contract has a ceiling value of $25,971.14 and is a firm fixed-price, non-set-aside contract. It has an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a Department of Defense agency, on May 5, 2023. The $22,563.14 firm fixed-price contract is for the supply of Biktarvy, a pharmaceutical product used in the treatment of HIV/AIDS. The contract has a period of performance through May 8, 2023 and was not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of the HIV medication Biktarvy. The contract has a ceiling value of $90,966.26 and is a firm fixed-price delivery order contract with a completion date of June 7, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,919.26, is for the supply of the HIV medication Biktarvy. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $144,071.44, is for the delivery of Biktarvy 50-200-25 mg tablet, a pharmaceutical product used in the treatment of HIV. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $68,293.08, is for the delivery of the drug Biktarvy, a combination tablet used to treat HIV-1 infection. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of February 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV. The contract has a ceiling value of $53,868.66 and a period of performance through April 24, 2025. This award is not set aside and represents open competition. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $26,778.46, is for the delivery of Biktarvy 50-200-25 mg tablets for a term ending on March 10, 2025. The contract is a firm fixed-price, delivery order type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC3G1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription drug Biktarvy, a combination medication used to treat HIV-1 infection. The contract has a firm fixed price of $10,040.72 and a performance period ending on May 15, 2025. This contract is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/13/25, 10:42 AM